NCT00695903: Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia |
|
|
| Terminated | 2 | 38 | US | daptomycin, Cubicin, daptomycin for injection, vancomycin, vancocin | Cubist Pharmaceuticals LLC | Endocarditis, Bacterial, Infective Endocarditis | 08/10 | 10/10 | | |
NCT02052388: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections |
|
|
| Completed | 2 | 215 | US | Daptomycin, Cubicin, Brilacidin, PMX63 | Cellceutix Corporation | Skin Infection, Bacterial Infection | 10/14 | 10/14 | | |
